BJA FY 11 Harold Rogers Prescription Drug Monitoring Program

archived

The primary purpose of the Harold Rogers Prescription Drug Monitoring Program (PDMP) is to enhance the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized state agency. The program was created by the FY 2002 U.S. Department of Justice Appropriations Act (Public Law 107-77) and has received funding under each subsequent year’s Appropriations Act.BJA was first appropriated funding for the Harold Rogers Prescription Drug Monitoring Program in FY 2002 and has received an appropriation every subsequent year. On August 11, 2005, the National All Schedules Prescription Electronic Reporting Act of 2005 (NASPER) was signed into law. Under NASPER, a formula grant program for state prescription monitoring programs was created to be administered by the Substance Abuse and Mental Health Services Administration (SAMHSA). Please note that currently, states can participate in both funding programs, but requirements and priorities for each program may vary. A comparison of these programs is attached.

High